Bellberry is delighted to welcome two new members of staff to the team, Reuben Jacob as Innovation Manager and Jerneen Williams as Early Phase Clinical Trials Manager.
Reuben has a background in science and genetics, and has spent the last decade working in research and in technology commercialisation. He previously worked for a State Government start-up grant program helping early-stage companies to develop and commercialise their intellectual property. At Bellberry, Reuben is responsible for implementing the Innovation Framework – which aims to improve internal processes and systems as well as seeking to solve the pain points of the national clinical trial sector. In the next few months, Reuben will be reaching out to Bellberry users to explore challenges and potential solutions. If you would like to be involved, please contact Reuben at reubenjacob@bellberry.com.au
Jerneen has worked in Cancer Clinical trials for 15 years, with a particular focus on early phase studies. She has a BSc in Genetics and a Masters of Medical Science in Clinical Trials (Research). Jerneen brings significant expertise and knowledge of clinical trials in the public health system to the Bellberry team, along with an understanding of the interactions between Ethics and Governance in the public sector. In the first instance, Jerneen will focus on assisting the training for new NSW-based users through the NSW Health Early Phase Clinical Trial Framework. Jerneen can be contacted at jerneenwilliams@bellberry.com.au
Both Reuben and Jerneen look forward to working with you and supporting you with your research programme.